Firecrest Clinical Ltd has been acquired by ICON plc
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has acquired Firecrest Clinical Ltd, a market leading provider of technology solutions that boost investigator site performance and study management, for an undisclosed consideration.
Founded in 2001 and headquartered in Limerick, Ireland, Firecrest Clinical provides a comprehensive site performance management system that has been used by nine of the world’s top-10 pharma companies to improve compliance, consistency and execution of activities at investigative sites. The web-based solution enables accurate study information, including protocol information, training manuals and case report forms, to be rolled out quickly and simultaneously to sites.
“We are delighted to be joining ICON at a time when technology is driving transformation within the pharmaceutical and clinical trials industry,” commented Gary Hughes, Firecrest CEO and co-founder. “Leveraging ICON’s global presence and deep client relationships will enable us to continue to grow and develop new and innovative technology solutions. We also see real synergies between both companies in terms of technology vision and look forward to combining the expertise from both companies to drive innovation.”
“Delivering consistent, real-time information to sites and a clear path to follow in the conduct of trials not only boosts the quality of trials, it also drives efficiencies and improves study timelines,” commented Peter Gray, CEO at ICON plc. “We have worked with Firecrest on a number of trials and have seen first hand how their technology improves quality through enhanced protocol compliance and drives efficiencies by reducing data queries and errors at sites. Our combined commitment to quality and our shared vision for using innovative technology to deliver more efficient and effective development programs make the companies a good fit.”
Oaklins' team in Ireland acted as the exclusive financial advisor to Firecrest Clinical´s shareholders in the sale of the company to ICON plc.
Contacter l'équipe de la transaction
Directeur généralDublin, Irlande
Bango plc growth capital for expansion
Bango plc has raised capital to finance its expansion plans.En apprendre plus
The management of Groupe JVS has led a new OBO alongside Parquest Capital and Bpifrance
Upon completion of this tertiary OBO, Groupe JVS’s management team, led by CEO Nebojsa Jankovic, increases its ownership and remains the majority shareholder of the group, alongside Parquest Capital and Bpifrance. Apax Partners Development and UI Gestion sold their shares after partnering for four years.En apprendre plus
Narva clinics has been acquired by Narva Åderbråckscenter AB
The founder and some key employees of Åderbråcksspecialisterna Narva Kirurg Center AB and Narva Derma Center AB (Narva) have completed an MBO.En apprendre plus